Gut Microbiota-Derived Short-Chain Fatty Acids Promote Poststroke Recovery in Aged Mice

Circ Res. 2020 Jul 31;127(4):453-465. doi: 10.1161/CIRCRESAHA.119.316448. Epub 2020 May 1.


Rationale: The elderly experience profound systemic responses after stroke, which contribute to higher mortality and more severe long-term disability. Recent studies have revealed that stroke outcomes can be influenced by the composition of gut microbiome. However, the potential benefits of manipulating the gut microbiome after injury is unknown.

Objective: To determine if restoring youthful gut microbiota after stroke aids in recovery in aged subjects, we altered the gut microbiome through young fecal transplant gavage in aged mice after experimental stroke. Further, the effect of direct enrichment of selective bacteria producing short-chain fatty acids (SCFAs) was tested as a more targeted and refined microbiome therapy.

Methods and results: Aged male mice (18-20 months) were subjected to ischemic stroke by middle cerebral artery occlusion. We performed fecal transplant gavage 3 days after middle cerebral artery occlusion using young donor biome (2-3 months) or aged biome (18-20 months). At day 14 after stroke, aged stroke mice receiving young fecal transplant gavage had less behavioral impairment, and reduced brain and gut inflammation. Based on data from microbial sequencing and metabolomics analysis demonstrating that young fecal transplants contained much higher SCFA levels and related bacterial strains, we selected 4 SCFA-producers (Bifidobacterium longum, Clostridium symbiosum, Faecalibacterium prausnitzii, and Lactobacillus fermentum) for transplantation. These SCFA-producers alleviated poststroke neurological deficits and inflammation, and elevated gut, brain and plasma SCFA concentrations in aged stroke mice.

Conclusions: This is the first study suggesting that the poor stroke recovery in aged mice can be reversed via poststroke bacteriotherapy following the replenishment of youthful gut microbiome via modulation of immunologic, microbial, and metabolomic profiles in the host.

Keywords: aging; fecal microbiota transplantation; gut microbiota; inflammation; metabolomics; middle cerebral artery occlusion.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Animals
  • Bifidobacterium longum / metabolism
  • Brain Chemistry
  • Clostridium symbiosum / metabolism
  • Faecalibacterium prausnitzii / metabolism
  • Fatty Acids, Volatile / analysis
  • Fatty Acids, Volatile / biosynthesis*
  • Fatty Acids, Volatile / blood
  • Fecal Microbiota Transplantation*
  • Feces / chemistry
  • Gastrointestinal Microbiome / physiology*
  • Infarction, Middle Cerebral Artery / therapy*
  • Interleukin-17 / biosynthesis
  • Intestines / chemistry
  • Intraepithelial Lymphocytes / physiology
  • Ischemic Stroke / therapy*
  • Limosilactobacillus fermentum / metabolism
  • Male
  • Mice
  • Mucin-2 / metabolism
  • Mucin-4 / metabolism
  • T-Lymphocytes, Regulatory / physiology


  • Fatty Acids, Volatile
  • Interleukin-17
  • Muc2 protein, mouse
  • Muc4 protein, mouse
  • Mucin-2
  • Mucin-4